Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Topical estrogen helps hair growth in menopausal women with no major side effects.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Combining cosmetic procedures with lifestyle changes improves antiaging results.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

The study suggests computer-assisted analysis of scalp biopsies could improve hair loss diagnosis but needs more validation.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Alopecia areata can look like frontal fibrosing alopecia, making diagnosis hard.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Smoking doesn't cause or prevent Frontal Fibrosing Alopecia, hormonal imbalance may be involved, and a combination of antiandrogens and steroids can help stabilize the condition.

Up to 50% of scalp hair can be lost before it appears thin, and treatment is only needed for hair loss caused by diseases or deficiencies.

Finasteride helps hair growth but may cause sexual side effects and depression.

Certain genes in fat tissue affect weight loss in women with PCOS.

Frontal fibrosing alopecia can sometimes look like syphilitic hair loss.

The document says that there are treatments for hair and nail diseases.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

An ovarian tumor can cause high male hormones in postmenopausal women.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Alopecia can often be managed effectively with various treatments, but early diagnosis is crucial for preventing permanent hair loss.

Combining modern and Unani medicine may better manage PCOS symptoms.

Postmenopausal women with excess male hormones may have ovarian tumors, and surgery usually cures them.

Menopause is a clear hormonal transition in women, while men experience a gradual testosterone decline, with some needing lifestyle changes and targeted therapy.

Biochemical markers help diagnose ovarian tumors in postmenopausal women.

A rare case of a woman having both lichen planus pigmentosus and classic lichen planopilaris at the same time.

A woman's increased facial hair and hair loss were caused by a rare ovarian tumor, cured by surgery.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.